FRIDAY, May 2 (HealthDay News) -- A number of potential new targets for treatments that block tumor blood vessel formation -- a key step in tumor growth and metastasis -- have been identified by researchers at the University of North Carolina at Chapel Hill.

By Steven Reinberg
EmpowHer's HealthDay Reporter

TUESDAY, April 15 (HealthDay News) -- Adding the cancer drug Avastin to radiation and chemotherapy improves results for patients with rectal cancer.

And adding the contraceptive drug mifepristone (RU-486, the so-called abortion pill) to chemotherapy kills ovarian cancer cells that escaped cisplatin treatment.

Those are the conclusions of two reports on new trends in cancer drugs presented Tuesday at the American Association for Cancer Research annual meeting, in San Diego.

By Ed Edelson
EmpowHer's HealthDay Reporter

WEDNESDAY, March 12 (HealthDay News) -- The sometimes controversial cancer drug Avastin can cause kidney damage by doing what it's supposed to -- but in the wrong place, a study shows.

Going against the recommendation of its advisory panel, the Food and Drug Administration cleared Avastin and judged the effectiveness of the drug based on measurements of tumor growth, not patient survival. Should the drug have been approved?

By Amanda Gardner
EmpowHer's HealthDay Reporter

FRIDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug Administration went against the recommendation of its own advisory panel on Friday and approved the cancer drug Avastin for women with advanced breast cancer.